| Field | Specification |
|---|---|
| Mfr No | |
| Product Type | |
| Shipping | |
| Species | |
| Storage |
Scientific Background
CD36 (cluster of differentiation 36) is also known as platelet glycoprotein 4, fatty acid translocase (FAT), scavenger receptor class B member 3 (SCARB3), and glycoprotein 88 (GP88). It is expressed in many cell types including erythrocytes, monocytes, differentiated adipocytes, skeletal muscle cells, mammary and intestinal epithelial cells, and endothelial cells. CD36 is one of the major glycoproteins present at the surface of platelets. CD36 has intricate biological functions, depending on the cell type and ligand. CD36 is a glycoprotein receptor for matrix proteins such collagen, fibronectin, and thrombospondin, acting as an adhesion molecule. Its binding to thrombospondin contributes to vascular biology and angiogenesis, and it also binds lipids such as oxidized phospholipids and low-density lipoprotein, lipoproteins, and long-chain fatty acids. Ligand-induced formation of CD36 clusters initiates signal transduction and internalization of receptor-ligand complexes. CD36 regulates cellular fatty acid metabolism in both health and disease by importing its lipid ligands inside cells and by facilitating the cellular uptake of long-chain fatty acids, thereby participating in muscle metabolism, energy storage in adipocytes, and the processing of dietary fat in the intestine. CD36 is involved in various diseases that involve the immune and vascular systems andin diseases for which lipid metabolism is important such as diabetes and obesity, inflammation, atherosclerosis, heart disease, and Alzheimer's disease. In addition, since lipids are an important energy source for tumor cells, CD36 is associated with cancer. Thus, upregulated CD36 expression has been observed in multiple types of cancer and is correlated with poor clinical outcomes. Finally, it plays a role in malaria through its capacity to mediate the adhesion of erythrocytes infected by the parasite responsible for the disease, Plasmodium falciparum.
Product Description
ImmunotherapyRecombinant clonal HEK293 cell line stably expressing full length human CD36. The stable clonal cell line was selected for medium and high levels of CD36 expression compared to the parental HEK293 cell line.
Product Specifications
| Host Cell Line | HEK293 |
|---|---|
| Host Species | Human |
| Transfection Method | Lipofectamine 2000 |
| Supplied As | Each vial contains 2 x 106 cells in 1 ml of cell freezing medium (BPS Bioscience, #79796) |
| Harmonized Tariff Code | 3002-5900 |
Quality Control & Validation
✓ Mycoplasma-TestedThe cell line has been screened to confirm the absence of Mycoplasma species.
Safety & Handling
⚠ Avoid freeze/thaw cycles.
Regulatory Information
License Disclosure
Related Products
Related Products: Cat. #90143, 101184
Required Accessories: Cat. #60187,78551,79796
This product is engineered on a HEK293 background (Human origin). The HEK293 host was selected for its compatibility with stable transfection and the target pathway or assay type. Consult the product datasheet for passage number guidance and recommended culture media.
This product is classified as BSL-2. Work must be performed in a certified BSL-2 laboratory by trained personnel. All procedures that may generate aerosols must be conducted inside a Class II Biological Safety Cabinet. Institutional Biosafety Committee (IBC) approval is required before use.
Yes. The cell line has been screened to confirm the absence of Mycoplasma species. We recommend that you independently confirm mycoplasma-negative status after receipt and periodically during routine culture using a validated detection kit.
Store this product at Liquid Nitrogen. Specifically: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage. Transfer cells from dry-ice shipping to the recommended storage immediately upon receipt. Avoid repeated freeze-thaw cycles, which reduce viability and may alter expression characteristics.
Yes, a license is required (Yes). Purchase of this cell line grants a time-limited research-use license for use in your immediate laboratory only. This license does not permit redistribution, sub-licensing, transfer to other institutions, or commercial use. Refer to the License Disclosure section on this page or contact BPS Bioscience for details regarding modifications or commercial licensing.
This stable cell line was generated using Lipofectamine 2000 for transgene delivery into the parental host. The stably integrated cells were selected using the appropriate resistance marker and verified for expression prior to cryopreservation.
Can't find the cell line you need—or require a custom engineered model for your study? We offer end-to-end support for diverse research needs, including:
- Cell line sourcing and selection (species, tissue, and disease model matching)
- Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA)
- Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs)
- Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles)
- Inducible expression systems (Tet-On/Off and regulatable constructs)
- Drug resistance marker selection (puromycin, G418, hygromycin, and others)
- Custom growth and media optimisation for specific assay requirements
- Scale-up production for high-throughput screening campaigns
- Authentication and QC services (STR profiling, mycoplasma testing, viability assessment)
Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.